Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Teladoc Health, Inc.TDOC · Entity 1547 | President, U.S. Group Health | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Teladoc Health, Inc.
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 92,832 |
Ending reported balance
After 2026-09-02 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-09-01 · Exercise / conversion · Acquired 4,859 · Balance 89,737 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 2 · 2026-09-01 · Exercise / conversion · Acquired 9,152 · Balance 98,889 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 3 · 2026-09-01 · Exercise / conversion · Acquired 1,300 · Balance 100,189 F2: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Row 4 · 2026-09-02 · Sale · Disposed 7,357 · Balance 92,832 F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 9,718 |
Reported balance
After 2026-09-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-01 · Exercise / conversion · Disposed 4,859 · Balance 9,718 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4: On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 54,918 |
Reported balance
After 2026-09-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-01 · Exercise / conversion · Disposed 9,152 · Balance 54,918 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 7,798 |
Reported balance
After 2026-09-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-01 · Exercise / conversion · Disposed 1,300 · Balance 7,798 F2: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F6: On March 1, 2026, the reporting person earned 15,596 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4: On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
F5: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6: On March 1, 2026, the reporting person earned 15,596 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 30, 2025 Filed Jun 3, 2025 21:36 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,858 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-25-000082 · wk-form4_1748986606.xml · nonDerivative · entry 3 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,919 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 21:36 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,488 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-25-000082 · wk-form4_1748986606.xml · nonDerivative · entry 2 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,061 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 21:36 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,189 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-25-000082 · wk-form4_1748986606.xml · nonDerivative · entry 1 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,573 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 20, 2025 Filed Mar 21, 2025 20:19 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 9,470 | $8.42 | $79,775.28 |
DisclosureSEC source: 0001477449-25-000031 · wk-form4_1742588377.xml · nonDerivative · entry 2 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,384 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 20:19 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 19,433 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000031 · wk-form4_1742588377.xml · derivative · entry 3 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,867 Underlying: Common Stock · 19,433 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. F3 · derivative.expiration_date: On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 20:19 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 19,433 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-25-000031 · wk-form4_1742588377.xml · nonDerivative · entry 1 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,854 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,904 | $9.68 | $28,122.34 |
DisclosureSEC source: 0001477449-25-000017 · wk-form4_1741122375.xml · nonDerivative · entry 4 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,421 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 109,832 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000017 · wk-form4_1741122375.xml · derivative · entry 8 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,832 Underlying: Common Stock · 109,832 shares Expires not disclosed F7 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F8 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F8 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000017 · wk-form4_1741122375.xml · derivative · entry 7 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,753 Underlying: Common Stock · 1,189 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 1, 2024, the reporting person earned 14,263 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: On March 1, 2024, the reporting person earned 14,263 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 3,488 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000017 · wk-form4_1741122375.xml · derivative · entry 6 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,952 Underlying: Common Stock · 3,488 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 41,853 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 41,853 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000017 · wk-form4_1741122375.xml · derivative · entry 5 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,404 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,189 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-25-000017 · wk-form4_1741122375.xml · nonDerivative · entry 3 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,488 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-25-000017 · wk-form4_1741122375.xml · nonDerivative · entry 2 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,404 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-25-000017 · wk-form4_1741122375.xml · nonDerivative · entry 1 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,648 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 22:20 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,040 | $11.93 | $24,331.08 |
DisclosureSEC source: 0001628280-24-049787 · wk-form4_1733264405.xml · nonDerivative · entry 4 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,244 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:20 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 3,488 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-049787 · wk-form4_1733264405.xml · derivative · entry 7 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,440 Underlying: Common Stock · 3,488 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 41,853 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 41,853 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:20 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-049787 · wk-form4_1733264405.xml · derivative · entry 6 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,404 Underlying: Common Stock · 1,404 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:20 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-049787 · wk-form4_1733264405.xml · derivative · entry 5 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,942 Underlying: Common Stock · 1,189 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2024, the reporting person earned 14,263 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On March 1, 2024, the reporting person earned 14,263 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:20 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,488 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-049787 · wk-form4_1733264405.xml · nonDerivative · entry 3 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,284 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:20 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,404 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-049787 · wk-form4_1733264405.xml · nonDerivative · entry 2 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,796 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:20 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,189 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-049787 · wk-form4_1733264405.xml · nonDerivative · entry 1 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,392 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| October 02, 2024 Filed Oct 2, 2024 20:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 897 | $8.68 | $7,783.27 |
DisclosureSEC source: 0001477449-24-000219 · wk-form4_1727900013.xml · nonDerivative · entry 2 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,203 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 2,631 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000219 · wk-form4_1727900013.xml · derivative · entry 3 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,631 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: On October 1, 2021, the reporting person was granted 7,892 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On October 1, 2021, the reporting person was granted 7,892 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,631 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000219 · wk-form4_1727900013.xml · nonDerivative · entry 1 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.